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Dental pulp stem cells (DPSCs) are increasingly being advocated for regenerative medicine-based therapies. However, significant
heterogeneity in the genotypic/phenotypic properties of DPSC subpopulations exists, influencing their therapeutic potentials. As
most studies have established DPSC heterogeneity using 2D culture approaches, we investigated whether heterogeneous DPSC
proliferative and contraction/remodelling capabilities were further evident within 3D type I collagen gels in vitro. DPSC
subpopulations were isolated from human third molars and identified as high/low proliferative and multipotent/unipotent,
following in vitro culture expansion and population doubling (PD) analysis. High proliferative/multipotent DPSCs, such as A3
(30 PDs and 80 PDs), and low proliferative/unipotent DPSCs, such as A1 (17 PDs), were cultured in collagen gels for 12 days,
either attached or detached from the surrounding culture plastic. Collagen architecture and high proliferative/multipotent DPSC
morphologies were visualised by Scanning Electron Microscopy and FITC-phalloidin/Fluorescence Microscopy. DPSC
proliferation (cell counts), contraction (% diameter reductions), and remodelling (MMP-2/MMP-9 gelatin zymography) of
collagen gels were also evaluated. Unexpectedly, no proliferation differences existed between DPSCs, A3 (30 PDs) and A1 (17
PDs), although A3 (80 PDs) responses were significantly reduced. Despite rapid detached collagen gel contraction with A3 (30
PDs), similar contraction rates were determined with A1 (17 PDs), although A3 (80 PDs) contraction was significantly
impaired. Gel contraction correlated to distinct gelatinase profiles. A3 (30 PDs) possessed superior MMP-9 and comparable
MMP-2 activities to A1 (17 PDs), whereas A3 (80 PDs) had significantly reduced MMP-2/MMP-9. High
proliferative/multipotent DPSCs, A3 (30 PDs), further exhibited fibroblast-like morphologies becoming polygonal within
attached gels, whilst losing cytoskeletal organization and fibroblastic morphologies in detached gels. This study demonstrates
that heterogeneity exists in the gel contraction and MMP expression/activity capabilities of DPSCs, potentially reflecting
differences in their abilities to degrade biomaterial scaffolds and regulate cellular functions in 3D environments and their
regenerative properties overall. Thus, such findings enhance our understanding of the molecular and phenotypic characteristics
associated with high proliferative/multipotent DPSCs.
1. Introduction
Adult human dental pulp stem cells (DPSCs) are increasingly
being characterised and evaluated as a viable mesenchymal
stem cell (MSC) source in the development of effective regen-
erative medicine-based therapies for clinical use [1–3]. Such
conclusions are based on DPSCs being readily accessible
from the permanent dentition, in addition to their self-
renewal, clonogenicity, and multilineage (e.g., osteogenic,
chondrogenic, adipogenic, myogenic, and neurogenic) differ-
entiation capabilities, comparable to those established for
bone marrow-derived MSCs [4–6]. Consequently, DPSCs
have already been shown to be beneficial to repair following
transplantation into various animal model defects in vivo,
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related to diseases and traumas within clinical fields such as
Dentistry, Orthopaedics, Neurology, Ophthalmology, and
Cardiology [1–3].
In order to replenish MSC populations and facilitate de
novo tissue repair, exogenously sourced MSCs are invariably
transplanted into wound sites seeded within three-
dimensional (3D) biomaterial scaffolds or hydrogels, which
act as cell carriers and provide mechanical support. Further-
more, the plethora of synthetic, semisynthetic, and naturally
derived scaffold materials currently used endeavor to recapit-
ulate the physiochemical properties of the extracellular
matrix (ECM) comprising the native stem cell niche micro-
environment, which actively controls MSC self-renewal, pro-
liferative, migratory, and differentiation responses [7–10].
Scaffold-based 3D assemblies provide a spatial arrangement
that permit multiple cellular interactions with MSCs via
integrin-based focal adhesions and Rho GTPases, which reg-
ulate cytoskeletal organization and cellular morphology, in
addition to mediating cell signalling, mechanical force trans-
duction, and adhesion to the biomaterial substratum [11, 12].
Most natural and semisynthetic biomaterial scaffolds are
designed to undergo gradual remodelling and degradation
by matrix metalloproteinases (MMPs), such as gelatinases
MMP-2 andMMP-9, to be replaced by the newly synthesized
tissue whilst still providing a functional role in supporting
MSC activity [13–16].
Despite such advances, fundamental challenges still
remain with the development of DPSC-based therapies for
clinical applications, due to the significant heterogeneity
between DPSCs isolated from dental pulp tissues, with indi-
vidual subpopulations demonstrating major differences in
proliferation and differentiation capabilities [4, 5, 17, 18].
Consequently, despite heterogeneous DPSC populations
achieving >120 population doublings (PDs) in vitro, only
20% of purified DPSCs are capable of proliferating >20
PDs. Such features have significant implications for DPSC
exploitation, as a major limitation of MSC-based therapies
is the extensive in vitro expansion required to produce suffi-
cient cell numbers for clinical use, which eventually leads to
proliferative decline, replicative senescence, and impaired
MSC regenerative properties [19, 20].
Recent studies by ourselves have demonstrated that
whilst high proliferative DPSCs are capable of >80 PDs in
culture, low proliferating DPSCs only completed <40 PDs
before senescence, correlating with DPSCs with high prolif-
erative capacities possessing longer telomeres than less pro-
liferative subpopulations [21, 22]. Low proliferative DPSC
senescence was also associated with the loss of stem cell
marker characteristics and impaired osteogenic/chondro-
genic differentiation, favouring adipogenesis. In contrast,
high proliferative DPSCs retained multipotency capabilities,
only demonstrating impaired differentiation following
prolonged in vitro expansion (>60 PDs).
Therefore, due to the established genotypic and pheno-
typic heterogeneity previously demonstrated to exist between
high proliferative/multipotent and low proliferative/unipo-
tent DPSC subpopulations utilising 2D monolayer cultures,
this study investigated whether similar DPSC heterogeneity
existed in terms of their respective proliferation and abilities
to remodel/contract 3D type I collagen gels in vitro. Specifi-
cally, the proliferative and ECM contraction/remodelling
capabilities of a high proliferative/multipotent DPSC sub-
population, A3, were evaluated at early (nonsenescent) stages
(at 30 PDs) and later (approaching senescence) stages (at 80
PDs) in its proliferative lifespan and compared against a low
proliferative/unipotent DPSC, A1, approaching senescence
(at 17 PDs). Type I collagen gels were employed, as they are
extensively used in the development of natural biomaterial
scaffolds for regenerative medicine applications [23, 24].
2. Materials and Methods
2.1. Dental Pulp Stem Cell Isolation and Characterisation of
Proliferation/Differentiation Capabilities in 2D Monolayer
Culture.Human DPSCs were isolated from third molar teeth
collected from patients (all female, age 18-30 years) undergo-
ing orthodontic extractions at the School of Dentistry, Car-
diff University, UK. Teeth were collected in accordance
with the Declaration of Helsinki (2013), with informed
patient consent and ethical approval by the South East Wales
Research Ethics Committee of the National Research Ethics
Service (NRES), UK.
Single cell suspensions of dental pulp tissues were
obtained, with DPSCs preferentially selected and isolated
from cell suspensions by differential fibronectin adhesion
assay [21]. Isolated cells were confirmed as DPSCs through
cell surface marker expression (positive for MSC markers,
CD73, CD90, and CD105, negative for hematopoietic stem
cell marker, CD45). DPSCs subsequently underwent
extended culture expansion and characterisation as being
high or low proliferative and multi- or unipotent. Prolifera-
tion analysis was based on the PDs reached by each DPSC
subpopulation prior to senescence, confirmed by the detec-
tion of other senescence-related markers, including reduced
telomere lengths, positive senescence-associated β-galactosi-
dase staining, and increased p53, p21waf1, and p16INK4a
expression [21].
Differentiation analyses were based on the abilities of
each DPSC subpopulation to undergo osteogenic, chondro-
genic, and adipogenic differentiation, via detection of estab-
lished differentiation markers as previously described [21].
Individual DPSC subpopulations were subsequently con-
firmed as being high proliferative/multipotent DPSCs (such
as A3, capable of >80 PDs) or low proliferative/unipotent
DPSCs (such as A1, capable of <40 PDs).
2.2. Preparation and Culture of 3D Type I Collagen Gels.
DPSCs were seeded in type I collagen gels, based on the
method of Stephens et al. [25]. Type I rat tail collagen
(>2mg/mL, First Link, Wolverhampton, UK) was reconsti-
tuted in an α-modified Minimum Essential Medium
(αMEM), containing ribonucleosides and deoxyribonucleo-
sides, supplemented with 4mM L-glutamine, 100U/mL pen-
icillin G sodium, 0.1μg/mL streptomycin sulphate,
0.25μg/mL amphotericin (all ThermoFisher Scientific, Pais-
ley, UK), and 100μM L-ascorbate 2-phosphate (Sigma,
Poole, UK), to provide 1mg/mL solutions. Collagen solu-
tions were neutralised by the dropwise addition of 5M
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sodium hydroxide. Subsequently, aliquots (1mL) of the col-
lagen solutions were added into each well of 12-well plate
and maintained at 37°C/5% CO2 for 45min. High proliferati-
ve/multipotent DPSC subpopulations, A3, at early (nonse-
nescent, 30 PDs) and late (approaching senescence, 80 PDs)
stages in their proliferative lifespans, and low proliferative/u-
nipotent DPSCs, A1 (approaching senescence, 17 PDs), were
suspended in αMEM, containing 20% gelatinase-free, foetal
calf serum (FCS, ThermoFisher Scientific, prepared from
complete FCS according to [26]). DPSCs (5 × 104 cells/mL)
in gelatinase-free αMEMwere subsequently added to the col-
lagen gels. Collagen gels (n = 3 per DPSC subpopulation)
were maintained at 37°C/5% CO2 for 12 days, with gels
remaining either attached to the surrounding tissue culture
plastic or detached at Day 0 using a sterile filter tip. Acellular
type I collagen gels were also established as controls.
2.3. Scanning Electron Microscopy (SEM) Analysis of
Acellular Collagen Gels. The architecture of type I collagen
fibres within the acellular gels was assessed by Scanning Elec-
tron Microscopy (SEM). Acellular collagen gels were estab-
lished as described above and fixed with 2.5%
glutaraldehyde (Agar Scientific, Stansted, UK) in 0.1M caco-
dylate buffer for 2 h at room temperature. Gels were subse-
quently washed (×3) with 0.1M cacodylate buffer and
dehydrated through a graded ethanol series: 30%, 50%,
70%, and 100% for 15min each, and gels allowed to dry over-
night. Dried hydrogels were sputter-coated and SEM images
taken at multiple locations throughout each gel, using a
S4800 Scanning Electron Microscope (Hitachi, Tokyo,
Japan), operated at 10 kV.
2.4. DPSC Proliferation in Type I Collagen Gels. Collagen gels
were also established as described above, for the high prolif-
erative/multipotent DPSC subpopulation, A3, at early (non-
senescent, 30 PDs) and late (approaching senescence, 80
PDs) stages in their proliferative lifespans, and low prolifera-
tive/unipotent DPSCs, A1 (approaching senescence, 17 PDs),
in order to assess their respective proliferative capabilities
over 12 days in culture. DPSCs were recovered at Days 1, 2,
4, 6, and 12 from collagen gels by enzymatic digestion, as pre-
viously described [25]. At each time point, collagen gels were
solubilized with collagenase A (400μL, 2mg/mL, Roche,
West Sussex, UK), at 37°C/5% CO2 for 2 h. This was followed
by incubation with 0.05% trypsin/0.53mM EDTA (100μL,
Thermo Fisher Scientific), at 37°C/5% CO2 for 20min.
DPSCs were recovered by centrifugation (1,500 g/5min)
and viable cell numbers determined using a Neubauer hae-
mocytometer, with 0.02% Trypan Blue solution (Sigma).
Each experiment was performed on 3 separate occasions.
2.5. Type I Collagen Gel Contraction by DPSCs. DPSC-seeded
collagen gels were established as described above. The rela-
tive extents of remodelling and contraction of the type I col-
lagen gels by high proliferative/multipotent DPSC
subpopulation, A3, at early (nonsenescent, 30 PDs) and late
(approaching senescence, 80 PDs) stages in their proliferative
lifespans, and low proliferative/unipotent DPSCs, A1
(approaching senescence, 17 PDs), were quantified from 3
separate gel diameter measurements performed on each rep-
licate sample (n = 3 per DPSC subpopulation), at Days 1, 2, 4,
6, and 12 in the culture. Average contraction values obtained
were expressed as % reduction in gel diameter, compared to
gel diameters at 0 h. Conditioned medium was also collected
from each individual well for the analysis of relative gelati-
nase (MMP-2 and MMP-9) activities at the same time points
as the gel diameter measurements. Each experiment was
performed on 3 separate occasions.
2.6. Assessment of Gelatinase (MMP-2 and MMP-9)
Activities. The relative amounts of pro- and active MMP-2
and MMP-9 activities produced by high proliferative/multi-
potent DPSC subpopulations, A3, at early (nonsenescent,
30 PDs) and late (approaching senescence, 80 PDs) stages
in their proliferative lifespans, and low proliferative/unipo-
tent DPSCs, A1 (approaching senescence, 17 PDs), in type I
collagen gels, were determined by gelatin zymography based
on the method of Stephens et al. [27]. Collected conditioned
media (25μL) were mixed with equal volumes of nonreduc-
ing Laemmli loading buffer and separated by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE), on precast
10% gelatin zymography gels (Ready Gel 10% Gelatin Zymo-
gram Gels, Bio-Rad Laboratories, Hemel Hempstead, UK),
using a Mini-PROTEAN® Tetra Cell System (Bio-Rad Labo-
ratories) at 20mA. SDS was removed from each SDS-PAGE
gel by washing in 2.5% Triton X-100 solution (Sigma), for
1 h at room temperature. Following electrophoresis, gelati-
nases within the SDS-PAGE gels were activated by incuba-
tion in 25mM Tris-HCl buffer, pH7.6, containing 5mM
calcium chloride (Sigma), 25mM sodium chloride (Thermo-
Fisher Scientific), and 5% Brij 35 (Sigma), at 37°C overnight.
Gels were stained with 0.05% Coomassie Blue solution
(Sigma) in 12% acetic acid and 54% methanol (both Thermo-
Fisher Scientific) and destained in 7.5% acetic acid/5% metha-
nol solution. Gel images were captured, with MMP-2 and
MMP-9 identified by the appearance of clear bands at compa-
rable molecular weights to loaded MMP-2 and MMP-9 stan-
dards, respectively. The relative amounts of MMP-2 and
MMP-9 in captured images were determined by densitometry,
using ImageJ® Software (https://imagej.nih.gov/ij/). Each
experiment was performed on 3 separate occasions.
2.7. SEM and Fluorescence Microscopy Analysis of DPSC
Morphologies in Collagen Gels. The cellular morphologies of
the nonsenescent (30 PDs), high proliferative/multipotent
DPSC subpopulation, A3, in type I collagen gels, were exam-
ined by both SEM and via actin cytoskeleton staining using
FITC-phalloidin and Fluorescence Microscopy. DPSC-
seeded collagen gels were established, as described above.
For SEM, collagen gels were fixed, processed, and visualised,
as per the methods detailed above. For Fluorescence Micros-
copy, DPSC-seeded collagen gels were washed with
phosphate-buffered saline (PBS, 1 × 1mL) and fixed with
4% paraformaldehyde (1mL, Santa Cruz, Dallas, USA) for
10min at room temperature. Gels were washed with PBS
(2 × 1mL) at 5min interval and treated with 0.3% Triton
X-100 (1mL) for 30min at room temperature, under con-
stant agitation. Gels were washed with Tris-buffered saline
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(TBS, pH7.5, 2 × 1mL) and blocked with 1% bovine serum
albumin (BSA, Fraction V, Thermo Fisher Scientific) in
TBS (1% BSA-TBS) for 1 h at room temperature, under con-
stant agitation. DPSC-seeded gels were stained with FITC-
phalloidin (20μg/mL, 1mL, Sigma) in 1% BSA-TBS and
incubated for 1 h at 4°C, under darkness and constant agita-
tion. Gels were washed with TBS (2 × 1mL) at 5min interval
and images captured by Fluorescence Microscopy (Olympus
Provis AX70 Microscope, Olympus UK Ltd., Southend-on-
Sea, UK).
2.8. Statistical Analysis. Each experiment was performed on
n = 3 independent occasions. Data were expressed as mean
± standard error of mean (SEM). Graphical data were ini-
tially confirmed as exhibiting homoscedasticity using
Levene’s test. Having shown that the averages for all experi-
mental group data were considered equal, graphical data
were subsequently compared statistically by Analysis of Var-
iance (ANOVA), performed using GraphPad InStat 3
(GraphPad Software Inc., La Jolla, USA). Statistical signifi-
cance was considered at p < 0:05.
3. Results
3.1. SEM Analysis of Acellular Collagen Gels. Representative
SEM images of the acellular collagen gels established using
the protocols described above are shown in Figures 1(a)
and 1(b). The matrix architecture is typical for type I collagen
gels of this nature, with the formation of a dense fibrillary
network of narrow, elongated, and crosslinked collagen fibres
[28, 29]. Consequently, the collagen fibre arrangements pro-
duced resulted in relatively small pore sizes being formed
within the collagen gels overall.
3.2. DPSC Proliferation in Type I Collagen Gels. Mean cell
numbers obtained for high proliferative/multipotent DPSC
subpopulations, A3, at early (nonsenescent, 30 PDs) and late
(approaching senescence, 80 PDs) stages in their proliferative
lifespans, and low proliferative/unipotent DPSCs, A1
(approaching senescence, 17 PDs), in attached and detached
type I collagen gels over 12 days in culture, are shown in
Figure 2. For attached collagen gels, all DPSC subpopulations
exhibited similar cell number profiles for the first 4 days
(Figure 2(a)). However, A3 (30 PDs) and A1 (17 PDs) subse-
quently began to increase in cell number to Day 6, followed
by reductions in cell numbers by Day 12 (all p > 0:05 between
A3, 30 PDs, and A1, 17 PDs). In contrast, A3 (80 PDs) failed
to exhibit any obvious increases in cell number beyond Day 4
(p < 0:05 versus A3, 30 PDs, and A1, 17 PDs, at Day 6).
With detached collagen gels, DPSCs A3 (30 PDs) and A1
(17 PDs) did not show any apparent increases in cell number
during the 12 days in culture, unlike the scenario under
attached type I collagen gel conditions (all p > 0:05,
Figure 2(b)). However, A3 (80 PDs) demonstrated compara-
ble cell number profiles under detached collagen gel condi-
tions, to their attached gel counterparts over the 12-day
culture period (all p > 0:05).
3.3. Type I Collagen Gel Contraction by DPSCs. Representa-
tive type I collagen gel contraction images for nonsenescent
(30 PDs), high proliferative/multipotent DPSC subpopula-
tions, A3, over 12 days in culture are shown in Figure 3(a).
Comparisons of mean collagen contraction values, expressed
as the % reduction in gel diameter compared to Day 0, dem-
onstrated that all DPSC subpopulations maintained in
attached collagen gels over the 12-day culture period did
not exhibit any gel contraction due to collagen gel attach-
ment to the adjacent tissue culture plastic (all p > 0:05; data
not shown). In contrast, DPSC subpopulations in detached
type I collagen gels with high proliferative/multipotent DPSC
subpopulations, A3, at early (nonsenescent, 30 PDs) and late
(approaching senescence, 80 PDs) stages in their proliferative
lifespans, and low proliferative/unipotent DPSCs, A1
(approaching senescence, 17 PDs), showed variable contrac-
tion rates over time (Figure 3(b)). For both A3 (30 PDs) and
A1 (17 PDs), gels displayed gradual decreases in diameter/-
contraction over the initial 4 days in culture, although gels
seeded with A3 (30 PDs) displayed greater contraction, com-
pared to A1 (17 PDs). However, from Day 6 onwards, gels
containing A1 (17 PDs) exhibited equivalent decreases in
diameter/contraction to A3 (30 PDs) gels. Consequently, no
significant differences were identified in the rates of type I
collagen contraction between gels seeded with A3 (30 PDs)
and A1 (17 PDs) throughout the 12-day culture period (all
p > 0:05). In contrast to A3 (30 PDs) and A1 (17 PDs), gels
seeded with A3 (80 PDs) displayed almost no shrinkage over
the first 6 days in culture, with only a total reduction in diam-
eter of ≅26% from its original size by Day 12 (Figure 3(b)). As
such, gels containing DPSC subpopulation A3 (80 PDs) dem-
onstrated significantly delayed gel contraction (all p < 0:001
‐0:01), compared to those seeded with A3 (30 PDs) and A1
(17 PDs).
3.4. Gelatinase Activities in DPSC-Seeded Collagen Gels. Rep-
resentative MMP-2 and MMP-9 gelatin zymography images
for high proliferative/multipotent DPSC subpopulations, A3,
at early (nonsenescent, 30 PDs) and late (approaching senes-
cence, 80 PDs) stages in their proliferative lifespans, and low
proliferative/unipotent DPSCs, A1 (approaching senescence,
17 PDs), in detached type I collagen gels over 12 days in cul-
ture, are shown in Figure 4. MMP zymography demonstrated
that pro-MMP-2 was detectable for all DPSC subpopulations
analysed, being detectable from Day 1 onwards, whilst active
MMP-2 was only detectable with A3 (30 PDs) and A1 (17
PDs, Figure 4(a)). Although MMP-2 activities gradually
increased over time in culture, A3 (80 PDs) demonstrated
the lowest levels of detectable pro- and active MMP-2 overall
(Figure 4(b)), being significantly less than A3 (30 PDs) and
A1 (17 PDs) at all time points (p < 0:001‐0:01 for pro-
MMP-2). However, significant differences in pro-MMP-2
activities between A3 (30 PDs) and A1 (17 PDs) were only
determined at Day 6 (p < 0:001). In contrast to MMP-2, A3
(30 PDs) was the only DPSC subpopulation to exhibit detect-
able pro-MMP-9 activities, being significantly higher than
A1 (17 PDs, all p < 0:001) and A3 (80 PDs, all p < 0:001)
throughout the culture duration (Figures 4(a) and 4(c)).
3.5. DPSC Morphologies in Type I Collagen Gels. As a conse-
quence of the rapid detached collagen gel contraction and
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unique MMP-9 expression/activity properties of the nonse-
nescent (30 PDs), high proliferative/multipotent DPSC sub-
population, A3, the cell morphologies of this subpopulation
were further examined in type I collagen gels by SEM and
Fluorescence Microscopy. SEM analysis demonstrated that
DPSCs possessed good biocompatibility with the collagen
gels overall, with viable cells detectable throughout the 12-
day culture duration. DPSCs were shown to attach to colla-
gen fibres and begin to spread at Day 1, with DPSCs largely
displaying flattened, spindle-shaped, or polygonal morphol-
ogies overall (Figures 5(a) and 5(b)). At Day 12, DPSCs had
spread further resulting in predominantly larger and more
irregular 3D cuboidal or polygonal morphologies, due to
superior interactions with the collagen matrices compared
to Day 1, through numerous contacts between cell extensions
and collagen fibres and the propagation of short
pseudopodia-like protrusions into the ECM from the cell
membranes (Figures 5(c) and 5(d)).
Representative Fluorescence Microscopy images of high
proliferative/multipotent DPSC subpopulation, A3 (30
PDs), cytoskeletal properties and morphologies in attached
and detached type I collagen gels at Day 1 are shown in
Figure 6. DPSCs exhibited limited morphological differences
throughout culture overall. However, whereas DPSCs in
attached type I collagen gels presented very clear actin stress
fibres with a fibroblastic-like appearance (Figure 6(a)),
DPSCs maintained in detached collagen gels appeared to lose
their fibroblastic appearance with less prominent actin fibres
(Figure 6(b)).
4. Discussion
This study was aimed at determining whether the well-
established in the proliferative, differentiation and other stem
cell properties between different DPSC subpopulations in the
2Dmonolayer culture were further identifiable in 3D cultures
within type I collagen gels. The concept of DPSC heterogene-
ity is well-established, with the presence of DPSC subpopula-
tions in dental pulp tissues possessing contrasting
proliferative and differentiation capabilities [4, 5, 17, 18].
Furthermore, recent corroborating findings have reported
key differences between DPSCs in the relative susceptibilities
(a) (b)
Figure 1: SEM images of the acellular type I collagen gels established using the protocols described herein, at (a) ×4,000 and (b) ×15,000
magnifications.
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Figure 2: Mean cell numbers for high proliferative/multipotent DPSC subpopulation, A3, at early (nonsenescent, 30 PDs) and late
(approaching senescence, 80 PDs) stages in their proliferative lifespans, and low proliferative/unipotent DPSCs, A1 (approaching
senescence, 17 PDs), following seeding in (a) attached and (b) detached type I collagen gels over 12 days in culture. N = 3, mean ± SEM, ∗
p < 0:05.
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to replicative senescence, correlating with contrasting telo-
mere lengths and the differentiation capabilities of individual
subpopulations [21, 22]. However, despite differences in the
genotypic/phenotypic characteristics of individual DPSC
subpopulations in vitro, to date, no studies had directly com-
pared whether similar differences in responses exist when
such DPSCs are seeded within 3D type I collagen gels. There-
fore, the present study compared the proliferative and ECM
contraction/remodelling capabilities of high proliferative/-
multipotent DPSC subpopulations, such as A3, at early (non-
senescent) stages (at 30 PDs) and later (approaching
senescence) stages (at 80 PDs) in its proliferative lifespan,
versus low proliferative/unipotent DPSCs, such as A1, whilst
approaching senescence (at 17 PDs).
A great deal of evidence exists confirming that cells
respond differently when cultured within 3D gel constructs,
in comparison to the 2D monolayer culture, ascribed to the
similarities between the 3D gel environment and the natural
ECM comprising the MSC niche [8]. Furthermore, the status
of 3D type I collagen and other gel types, in terms of whether
these are detached or remain attached to the surrounding tis-
sue culture plastic, has been previously shown to regulate cel-
lular behaviour, including morphology, proliferation, and
differentiation, in addition to contraction itself [30–34].
SEM and Fluorescence Microscopy analyses demonstrated
that DPSCs, such as the high proliferative/multipotent sub-
population, A3, at nonsenescent stages in its proliferative life-
span (at 30 PDs), readily interacted and spread within type I
collagen gels, particularly possessing spindle-shaped,
fibroblast-like morphologies with obvious actin stress fibres,
during early culture in attached type I collagen gels. More
polygonal DPSC morphologies developed during prolonged
culture due to superior interactions with the type I collagen
matrices. In contrast, this DPSC subpopulation lost its
fibroblast-like morphologies with less prominent actin fibres
evident, when seeded within detached type I collagen gels.
Collagen gel contraction by resident cells causes mechanical
forces to be induced within the surrounding ECM, capable
of influencing cellular alignment depending on the forces
encountered [30]. As described below, type I collagen gel
contraction by this DPSC subpopulation was particularly
apparent during early culture stages, such as between Day 0
and Day 1. Thus, it was hypothesized that any prominent dif-
ferences in the cytoskeletal organization between the
attached and detached type I collagen gels would be particu-
larly evident by Day 1, as was proven to be the case. Hence, as
evident here, cells within attached gels alone develop isomet-
ric tension by forming prominent cytoskeletal actin stress
fibres and focal adhesions with the surrounding ECM, per-
mitting pseudopodia to aid their attachment or movement
within the type I collagen environment [35–37].
Various cell types have also previously been shown to
undergo mechanical stress-induced proliferation within
attached collagen gels [31–33]. Despite increased DPSC
numbers towards the latter stages of culture within attached
type I collagen gels, relatively modest increases in DPSC
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Figure 3: (a) Images of detached type I collagen gel contraction by nonsenescent (30 PDs), high proliferative/multipotent DPSC
subpopulation, A3, over 12 days in culture. (b) Mean % detached type I collagen gel contraction by high proliferative/multipotent DPSC
subpopulation, A3, at early (nonsenescent, 30 PDs) and late (approaching senescence, 80 PDs) stages in their proliferative lifespans, and
low proliferative/unipotent DPSCs, A1 (approaching senescence, 17 PDs), over 12 days in culture. N = 3, mean ± SEM, ∗∗∗p < 0:001, ∗∗p <
0:01.
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proliferation were evident overall throughout the 12-day cul-
ture period. In contrast, detached gels showed minimal pro-
liferation for all DPSC subpopulations analysed [38, 39].
However, cell number comparisons between high proliferati-
ve/multipotent DPSC subpopulations, A3, at early (nonse-
nescent, 30 PDs) and late (approaching senescence, 80 PDs)
stages in their proliferative lifespans, and low proliferative/u-
nipotent DPSCs, A1 (approaching senescence, 17 PDs),
within attached type I collagen gels, revealed significantly
impaired A3 (80 PDs) proliferative responses in 3D culture,
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Figure 4: (a) Representative gelatin zymography gel images of pro- and active MMP-9/MMP-2 activities for high proliferative/multipotent
DPSC subpopulation, A3, at early (nonsenescent, 30 PDs) and late (approaching senescence, 80 PDs) stages in their proliferative lifespans,
and low proliferative/unipotent DPSCs, A1 (approaching senescence, 17 PDs), following seeding in detached type I collagen gels over 12
days in culture. Pro-MMP-2, active MMP-2, and pro-MMP-9 were detectable at 72 kDa, 62 kDa, and 92 kDa, respectively. Densitometry
quantification of (b) pro-MMP-2 and (c) pro-MMP-9 activities for high proliferative/multipotent DPSC subpopulation, A3 (30 PDs and
80 PDs), and low proliferative/unipotent DPSC subpopulation (A1, 17 PDs), following seeding in detached type I collagen gels over 12
days in culture. N = 3, mean ± SEM, ∗∗∗p < 0:001, ∗∗p < 0:01.
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compared to earlier in their proliferative lifespan (30 PDs).
Intriguingly, no significant differences in proliferation were
identifiable between A3 (30 PDs) and A1 (17 PDs), despite
considerable differences in their proliferative capacities and
susceptibilities to replicative senescence being previously
identified in the 2D monolayer culture (>80 PDs versus
<40 PDs, respectively; [21]). Therefore, obvious differences
in proliferative capacities between A3 (80 PDs) and A3 (30
PDs) may be accounted for by the relative stages in their pro-
liferative lifespan where this DPSC subpopulation was
assessed, although the precise reasons behind such discrep-
ancies in the relative proliferative responses of A3 (30 PDs)
and A1 (17 PDs) between 2D and 3D environments remain
to be elucidated.
Although studies have determined that cells proliferate
poorly in detached gels due to their growth arrest within
the G0/G1 phase of the cell cycle [40], the principle reasons
underlying the maintenance of cellular proliferative capabili-
ties within attached gels remain to be fully determined.
Nonetheless, cell signalling pathways, such as ERK or MAP
kinases, are acknowledged to respond to various stimuli,
including mechanical stress, whilst such signalling cascades
are not initiated in detached collagen gels, due to the absence
of isometric tension and cytoskeletal actin stress fibre
(a) (b)
(c) (d)
Figure 5: SEM images of nonsenescent (30 PDs), high proliferative/multipotent DPSC subpopulation, A3, following seeding in type I
collagen gels at (a) Day 1 (×700 magnification), (b) Day 1 (×2,500 magnification), (c) Day 12 (×1,100 magnification), and (d) Day 12
(×3,500 magnification).
500 𝜇m
(a)
500 𝜇m
(b)
Figure 6: Fluorescence Microscopy images of FITC-phalloidin cytoskeletal staining of nonsenescent (30 PDs), high proliferative/multipotent
DPSC subpopulation, A3, following seeding in (a) attached type collagen gels and (b) detached type collagen gels, at Day 1. ×100
magnification. Scale bar = 500 μm.
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formation [41, 42]. Therefore, it is plausible that similar dif-
ferences in ERK and MAPK signalling exist between the
DPSC subpopulations within attached and detached type I
collagen gels herein and warrant further investigation.
Cellular functions within the stem cell niche or biomate-
rial scaffolds are tightly regulated by the ECMmicroenviron-
ment, remodelled by proteinases such as MMPs [43, 44]. Of
the different MMP groups known, gelatinases MMP-2 and
MMP-9 have common roles in mediating MSC remodelling
of the niche and biomaterial scaffold degradation, thereby
facilitating cellular activities [13–16]. Analysis of the relative
abilities of high proliferative/multipotent DPSC subpopula-
tions, A3, at early (nonsenescent, 30 PDs) and late
(approaching senescence, 80 PDs) stages in their proliferative
lifespans, and low proliferative/unipotent DPSCs, A1
(approaching senescence, 17 PDs), to remodel and contract
detached type I collagen gels, demonstrated initial rapid col-
lagen gel contraction with A3 (30 PDs), although comparable
rates of gel contraction between A3 (30 PDs) and A1 (17
PDs) were identified overall during the 12-day culture dura-
tion. In contrast, A3 (80 PDs) displayed significantly
impaired gel contraction capabilities, as a likely consequence
of this being at the latter stages in its proliferative lifespan
and more senescent than its lesser senescent A3 (30 PDs)
counterparts. Such gel contraction findings were ascribed to
contrasting MMP-2 and MMP-9 activities detected for each
DPSC subpopulation, with significantly elevated levels of
pro- and active forms of MMP-2 and MMP-9 being respon-
sible for collagen gel contraction by a high proliferative/mul-
tipotent DPSC subpopulation, A3 (30 PDs), and pro- and
active forms of MMP-2 alone for gel contraction by a low
proliferative/unipotent DPSC subpopulation, A1 (17 PDs).
However, A3 (80 PDs) demonstrated significant reduced
pro- and active MMP-2 and MMP-9 activities overall.
Similarly impaired type I collagen gel reorganizational
capabilities have previously been reported with other senes-
cent cell populations, partly as a consequence of reduced
MMP-2 expression and activities [45, 46]. Replicative senes-
cence is also well-established to induce significant alterations
inMSC genotype and phenotype, leading to impaired cellular
regenerative properties and signalling mechanisms via the
secretome associated with the senescence-associated secre-
tory phenotype (SASP) [20, 47]. However, despite the SASP
being accompanied by excessive expression of proinflamma-
tory mediators, including MMPs, excessive MMP-2 and/or
MMP-9 activities by more senescent A3 (80 PDs) were not
detectable herein, as DPSC subpopulation, A3, lost its abili-
ties to express MMP-2 and MMP-9 with extensive culture
expansion in line with previous findings [45, 46]. Further-
more, in addition to limited type I collagen gel contraction
and MMP-2/MMP-9 activities by A3 (80 PDs), superior
remodelling efficiencies were only evident with A3 (30 PDs)
at certain time points, compared to the more senescent sub-
population, A1 (17 PDs).
Although there are many similarities between gelatinases,
MMP-2 and MMP-9, in terms of their structures and sub-
strates, differences in their cellular sources, regulation, and
activation do exist [43, 44]. Gelatinase expression and activa-
tion are regulated by numerous factors, including cytokines
and growth factors. Mechanical stress is also a key factor
capable of regulating MMP expression and activities within
3D gel environments during contraction, whilst MSC func-
tions have also been shown to be highly regulated by MMPs
[14, 16, 48–51]. Despite the inactive zymogens of MMP-2
and MMP-9 existing as proforms due to the presence of
latent propeptide domains, differences in prodomain cleav-
age and proteolytic activation by other MMPs or proteinases
are acknowledged. Pro-MMP-2 activation can be mediated
via a broad range of MMPs, most significantly through com-
plex formation with membrane-type MMPs (MT-MMPs)
and tissue inhibitor of metalloproteinases (TIMPs) [43, 44].
However, unlike pro-MMP-2, MT-MMP-/TIMP-dependent
mechanisms of activation have not been described for pro-
MMP-9, which is mediated by alternative MMP-driven
mechanisms. Indeed, although MMP-2 is a key contributor
to the proteolytic activation of pro-MMP-9, it is established
that pro-MMP-9 predominantly remains in its latent pro-
form during the culture of many different cell types, even in
the presence of active MMP-2 [52]. Thus, a paradox remains
as to the lack of active MMP-9 under cell culture conditions,
although structural and catalytic differences between these
gelatinases and their sequestration within the ECM have
been suggested to contribute to this phenomenon [43, 44].
Nonetheless, the nonsenescent high proliferative/multipo-
tent DPSC subpopulation, A3 (30 PDs), was unique in dem-
onstrating pro-MMP-9 detection. Thus, as pro-MMP-9 is
recognised to possess significant catalytic activity, even with
the propeptide domain intact [53], the absence of active
MMP-9 should not curtail the potential significance of pro-
MMP-9 in facilitating type I collagen gel remodelling by
these DPSC subpopulations. Indeed, this mechanism could
be important for MSC maintenance in a quiescent state
within the stem cell niche or in enhancing the 3D biomaterial
scaffold remodelling/degradation capabilities of this DPSC
subpopulation [15, 49]. Furthermore, pro-MMP-9 detection
in the high proliferative/multipotent subpopulation, A3, at
nonsenescent stages in its proliferative lifespan (at 30 PDs),
may indicate another feature of the heterogeneous nature
between DPSCs isolated from dental pulp tissues [4, 5, 17,
18, 21, 22]. However, we can only speculate at present as to
the reasons underlying such differences in type I collagen
gel contraction and MMP remodelling capabilities between
high proliferative/multipotent and low proliferative/unipo-
tent DPSCs, as patient donor features, developmental origins,
stem cell niche sources, and/or the stages of commitment of
these DPSC subpopulations would undoubtedly be potential
influences on these cellular characteristics.
5. Conclusions
As with previous studies highlighting the phenotypic and
genotypic heterogeneity which exists between high prolifera-
tive/multipotent and low proliferative/unipotent DPSC sub-
populations utilising 2D monolayer cultures, this study
demonstrates that heterogeneity is also evident in terms of
the gel contraction capabilities and MMP expression/activity
profiles of individual DPSC subpopulations, following seed-
ing within 3D type I collagen gels. Despite distinct differences
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in proliferative capabilities and susceptibilities to replicative
senescence between DPSC subpopulations previously being
established during the extended 2D monolayer culture, con-
trasting proliferative responses were unexpectedly less appar-
ent within 3D collagen gels. Such variations in type I collagen
remodelling mechanisms by MMP-2 and MMP-9 between
high proliferative/multipotent and low proliferative/unipo-
tent DPSC subpopulations may reflect novel differences in
their respective abilities to degrade biomaterial scaffolds
and regulate cellular functions in 3D environments following
in vivo transplantation, thereby influencing their individual
regenerative properties overall. Consequently, these findings
also aid our understanding of the molecular and phenotypic
properties associated with high proliferative/multipotent
DPSCs, which may be exploited for their selective screening
and isolation from dental pulp tissues for regenerative medi-
cine applications.
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